33 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
2 Nov 22
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:11am
, highlighted by our product candidates ONCR-021 and ONCR-788, involves a highly innovative, novel combination of RNA and LNP-based modalities designed
8-K
EX-99.1
ONCR
Oncorus, Inc.
4 Aug 22
Oncorus Reports Second Quarter 2022 Financial Results and Provides Business Updates
9:04am
a highly innovative, novel combination of RNA and oncolytic virus-based modalities designed to realize the potential of RNA medicines for cancer.
Please
8-K
EX-99.1
ONCR
Oncorus, Inc.
23 Jun 22
Oncorus Appoints Douglas Fambrough to Board of Directors
7:21am
in financing innovative life science technology companies. While at Oxford, Dr. Fambrough led the investment in the first-generation RNA interference … ) Immunotherapy Platform, highlighted by our product candidates ONCR-021 and ONCR-788, involves a highly innovative, novel combination of RNA and oncolytic
8-K
ONCR
Oncorus, Inc.
23 Jun 22
Oncorus Appoints Douglas Fambrough to Board of Directors
7:21am
innovative life science technology companies, including Dicerna Pharmaceuticals, Sirna Therapeutics, Inc. (acquired by Merck & Co., Inc.), Solexa, Inc
8-K
EX-99.1
bwwxtklhjmm
4 May 22
Oncorus Reports First Quarter 2022 Financial Results and Provides Business Updates
7:15am
8-K
EX-99.1
zu0pw8nsa060cibxa19
5 Apr 22
Entry into a Material Definitive Agreement
7:10am
8-K
EX-99.1
0eds84y9fzo jsklw
9 Mar 22
Oncorus Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:46am
8-K
EX-99.1
6ph a40fn
10 Jan 22
Regulation FD Disclosure
8:17am
8-K
EX-99.1
t90248g ub2gwxl4oex
12 Nov 21
Entry into a Material Definitive Agreement
7:45am
8-K
EX-99.1
kbjj25syq5yxtckt
9 Nov 21
Regulation FD Disclosure
8:10am
8-K
EX-99.1
wj55erf2295ci
3 Nov 21
Oncorus Reports Third Quarter 2021 Financial Results and Provides Business Updates
7:18am
8-K
EX-99.1
stf7k0r
4 Aug 21
Oncorus Reports Second Quarter 2021 Financial Results and Provides Business Highlights
7:09am
8-K
EX-99.1
stqxibtc8147vm
29 Jul 21
Oncorus Expands its Board with Appointment of Barbara Yanni
4:31pm
8-K
EX-99.1
j0fctny zk4
21 Jun 21
Oncorus Appoints Eric Rubin, M.D. to its Board of Directors
4:03pm
8-K
EX-99.1
0bxlao4a9nw
15 Jun 21
Regulation FD Disclosure
7:15am
8-K
EX-99.1
81zoqd l8o49j75w7
27 May 21
Regulation FD Disclosure
7:15am